A controlled study of topical 0.25% timolol maleate gel for the treatment of cutaneous infantile capillary hemangiomas

Ophthalmic Plastic and Reconstructive Surgery

Volumn 28, Issue 2, 2012, Pages 103-106

  Chambers, Christopher B ^a   Katowitz, William R ^b,c   Katowitz, James A ^b,c   Binenbaum, Gil ^b,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; PROPRANOLOL; TIMOLOL MALEATE;

ARTICLE; ASTIGMATISM; CAPILLARY HEMANGIOMA; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EYE PHOTOGRAPHY; EYE TUMOR; FOLLOW UP; GEL; HUMAN; INFANT; PRIORITY JOURNAL; PTOSIS; RETROSPECTIVE STUDY; SKIN TUMOR; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADRENERGIC BETA-ANTAGONISTS; FOLLOW-UP STUDIES; GELS; HEMANGIOMA, CAPILLARY; HUMANS; INFANT; ORBITAL NEOPLASMS; RETROSPECTIVE STUDIES; SINGLE-BLIND METHOD; SKIN NEOPLASMS; TIMOLOL; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84860877536     PISSN: 07409303     EISSN: 15372677     Source Type: Journal    
DOI: 10.1097/IOP.0b013e31823bfffb     Document Type: Article

References (11)

1. Kilcline C, Frieden IJ. Infantile hemangiomas: how common are they? A systematic review of the medical literature. Pediatr Dermatol 2008;25:168-73. (Pubitemid 351579596)
2. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358:2649-51. (Pubitemid 351831393)
3. Mishra A, Holmes WJ, Gorst C, Liew SH. Role of propranolol in the management of periocular hemangiomas. Plast Reconstr Surg 2010;126:671.
4. Rosbe KW, Suh KY, Meyer AK, et al. Propranolol in the manage-ment of airway infantile hemangiomas. Arch Otolaryngol Head Neck Surg 2010;136:658-65.
5. Storch CH, Hoeger PH. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action. Br J Dermatol 2010;163:269-274.
6. Guo S, Ni N. Topical treatment for capillary hemangioma of the eye-lid using beta-blocker solution. Arch Ophthalmol 2010;128:255-6.
7. Ni N, Langer P, Wagner R, Guo S. Topical timolol for perio-cular hemangioma: report of further study. Arch Ophthalmol 2011;129:377-9.
8. Pope E, Chakkittakandiyil A. Topical timolol gel for infantile hemangiomas: a pilot study. Arch Dermatol 2010;146:564-5.
9. Plager DA, Whitson JT, Netland PA, et al. Betaxolol hydrochloride ophthalmic suspension 0.25% and timolol gel-forming solution 0.25% and 0.5% in pediatric glaucoma: a randomized clinical trial. J AAPOS 2009;13:384-90.
10. Hoskins HD Jr, Hetherington J Jr, Magee SD, et al. Clinical experience with timolol in childhood glaucoma. Arch Ophthalmol 1985;103:1163-5. (Pubitemid 15024628)
11. Ohno Y, Iga T, Yamada Y, et al. Pharmacokinetic and pharmaco-dynamic analysis of systemic effect of topically applied timolol maleate ophthalmic gelling vehicle (Rysmon TG). Curr Eye Res 2005;30:319-28. (Pubitemid 40806653)